Holen Sie sich die Stockscreener-App
2.62
0.77%
0.01
Handel nachbörslich:
2.63
0.010
+0.38%
Schlusskurs vom Vortag:
$2.61
Offen:
$2.61
24-Stunden-Volumen:
990.12K
Relative Volume:
0.11
Marktkapitalisierung:
$41.94M
Einnahmen:
$1.38M
Nettoeinkommen (Verlust:
$-179.05M
KGV:
-0.4267
EPS:
-6.14
Netto-Cashflow:
$-155.03M
1W Leistung:
+5.20%
1M Leistung:
-15.43%
6M Leistung:
+36.98%
1J Leistung:
+390.31%
1-Tages-Spanne:
$2.522
$2.71
1-Wochen-Bereich:
$2.46
$2.87
52-Wochen-Spanne:
$0.16
$8.08
Bioxcel Therapeutics Inc Stock (BTAI) Company Profile
Firmenname
Bioxcel Therapeutics Inc
Sektor
Branche
Telefon
203-643-8060
Adresse
555 LONG WHARF DRIVE, NEW HAVEN, CT
Vergleichen Sie BTAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BTAI
Bioxcel Therapeutics Inc
|
2.62 | 51.28M | 1.38M | -179.05M | -155.03M | -6.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bioxcel Therapeutics Inc Stock (BTAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-21 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-15 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-07-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-03-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-01 | Hochstufung | Goldman | Sell → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-06 | Bestätigt | BofA Securities | Buy |
| 2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
| 2021-04-09 | Eingeleitet | Berenberg | Buy |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-30 | Eingeleitet | Goldman | Buy |
| 2020-09-02 | Eingeleitet | Jefferies | Buy |
| 2020-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-04 | Eingeleitet | Guggenheim | Buy |
| 2020-04-01 | Eingeleitet | BofA/Merrill | Buy |
| 2020-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-01-08 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
Alle ansehen
Bioxcel Therapeutics Inc Aktie (BTAI) Neueste Nachrichten
BioXcel Therapeutics Rings the Closing Bell - Nasdaq
BioXcel Therapeutics (BTAI) Reports Positive Study Results Suppo - GuruFocus
BioXcel reports positive correlation study results for BXCL501 By Investing.com - Investing.com Nigeria
BioXcel Announces Positive SERENITY At Home Study Results - TipRanks
BioXcel Reports Results From Correlation Study Related To Efficacy Outcomes From SERENITY Trial - Nasdaq
BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes - The Manila Times
BioXcel Therapeutics Announces Positive Study Results for SERENITY At Home Trial - TradingView
ρ=0.89 correlation supports at‑home mCGI‑S efficacy — BioXcel Therapeutics to include data in sNDA planned Q1 2026 - Stock Titan
Published on: 2025-10-14 04:30:13 - newser.com
Why BioXcel Therapeutics Inc. stock could see breakout soonInsider Buying & Breakout Confirmation Trade Signals - newser.com
Published on: 2025-10-13 07:29:55 - newser.com
BioXcel Therapeutics to Ring Nasdaq Closing Bell on October - GlobeNewswire
SERENITY At-Home pivotal trial completed: BioXcel to ring Nasdaq closing bell Oct 14, 2025 - Stock Titan
Strategies to average down on BioXcel Therapeutics Inc.Trade Analysis Summary & Smart Money Movement Tracker - newser.com
BioXcel Therapeutics announces pricing of $7M public offering - MSN
Why BioXcel Therapeutics, Inc. (BTAI) Soared Last Week - MSN
BioXcel Therapeutics Inc. stock outlook for YEARShare Buyback & Low Drawdown Momentum Ideas - newser.com
How BioXcel Therapeutics Inc. (BX20) stock reacts to stronger dollarWeekly Stock Analysis & Low Risk Profit Maximizing Plans - newser.com
BioXcel Therapeutics Receives Positive FDA Feedback - MSN
Sentiment analysis tools applied to BioXcel Therapeutics Inc.Weekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Is BioXcel Therapeutics Inc. stock a smart buy before Fed meetingJuly 2025 Movers & High Conviction Trade Alerts - newser.com
BioXcel Therapeutics Inc. stock daily chart insights2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
What drives BioXcel Therapeutics Inc BX20 stock pricePrice Action Analysis & Double Or Triple Wealth - earlytimes.in
How BioXcel Therapeutics Inc. (BX20) stock responds to bond marketJuly 2025 Outlook & Growth Focused Entry Reports - newser.com
Will BioXcel Therapeutics Inc. stock recover faster than peersQuarterly Portfolio Report & Weekly Watchlist for Hot Stocks - newser.com
Is BioXcel Therapeutics Inc. stock reversal real or fakeEarnings Recap Summary & Growth Focused Stock Pick Reports - newser.com
BioXcel Therapeutics Inc. stock chart pattern explained2025 Market Sentiment & Community Driven Trade Alerts - newser.com
BioXcel Investors Advance Suit Over FDA Study Compliance Issues - Bloomberg Law News
What analysts say about BioXcel Therapeutics Inc stockMean Reversion Trades & Market Monitoring and Alerts - earlytimes.in
Finanzdaten der Bioxcel Therapeutics Inc-Aktie (BTAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):